TechSci Healthcare Industry Report

  Growing prevalence of cardiovascular diseases is expected to drive the growth of India valsartan market. According to TechSci Research report,  “ India  Valsartan Market  By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Heart Failure, Myocardial Infarction, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” ,  the India valsartan market is expected to grow at a formidable rate during the forecast period on account of the changing lifestyle patterns, lack of physical exercises, intake of junk food and improper dietary habits. This has led to increasing incidences of obesity, diabetes, cardiovascular diseases, among others. This in turn is expected to positively influence the market growth over the next few years. Additionally, valsartan is widely used in the treatment of dia...

  Growing prevalence of bacterial infections is expected to drive the growth of India ciprofloxacin market. According to TechSci Research report,  “ India  Ciprofloxacin Market  By Composition (Single v/s Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure Infections, Bone and Joint infections, Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India ciprofloxacin market is expected to grow at an impressive rate during the forecast period on account of the increasing application in the tre...

Growing prevalence of bacterial infections is expected to drive the growth of India tinidazole market. According to TechSci Research report,  “ India  Tinidazole Market  By Industry (Chemical Industry v/s Pharmaceutical Industry), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Injection, Capsule, Syrup, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Amoebiasis, Amoebic liver Abscess, Bacterial vaginosis, Giardiasis, Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India tinidazole market is expected to grow at a formidable rate during the forecast period on account of the widespread use of medication in treatment of Amoebiasis, Amoebic Liver Abscess, Bacterial Vaginosis, Giardiasis, Trichomoniasis, among others. Additionally, it is used as a therapeutic alternative in cases of metronidazo...

  Growing prevalence of bacterial infections is expected to drive the growth of India clindamycin HCL market. According to TechSci Research report,  “ India Clindamycin HCL Market  By Product Type (OTC v/s Prescription), By Route of Administration (Oral, Topical, Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Cream, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Ear Infections, Meningitis, Malaria, Toxoplasmosis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India clindamycin HCL market is expected to grow at a steady rate during the forecast period on account of the extensive use of drug in treatment of blood infections, septicemia, abdominal infections, lung infections, infections of female reproductive tract, skin infections, among others. Additionally, the medication can be used to treat ...

Growing prevalence of hypertension is expected to drive the growth of India Telmisartan market. According to TechSci Research report,  “ India  Telmisartan Market  By Indication (Hypertension, Cardiac Arrest, Stroke, Others), By Composition (Single, Combinational), By Form (Tablet, Capsule, Injection, Others), By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India telmisartan market is expected to grow at a steady rate during the forecast period for the treatment of essential hypertension. In addition to this, rising demand for developing antihypertensive drugs is expected to fuel the market growth through FY2026. However, side-effects associated with drug consumption such as upper respiratory tract infections, diarrhea, back pain, kidney problems, low blood pr...